271 reports of this reaction
8.7% of all ADAPALENE AND BENZOYL PEROXIDE reports
#1 most reported adverse reaction
ERYTHEMA is the #1 most commonly reported adverse reaction for ADAPALENE AND BENZOYL PEROXIDE, manufactured by Galderma Laboratories, L.P.. There are 271 FDA adverse event reports linking ADAPALENE AND BENZOYL PEROXIDE to ERYTHEMA. This represents approximately 8.7% of all 3,122 adverse event reports for this drug.
Patients taking ADAPALENE AND BENZOYL PEROXIDE who experience erythema should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
ERYTHEMA is moderately reported among ADAPALENE AND BENZOYL PEROXIDE users, representing a notable but not dominant share of adverse events.
In addition to erythema, the following adverse reactions have been reported for ADAPALENE AND BENZOYL PEROXIDE:
The following drugs have also been linked to erythema in FDA adverse event reports:
ERYTHEMA has been reported as an adverse event in 271 FDA reports for ADAPALENE AND BENZOYL PEROXIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
ERYTHEMA accounts for approximately 8.7% of all adverse event reports for ADAPALENE AND BENZOYL PEROXIDE, making it one of the most commonly reported side effect.
If you experience erythema while taking ADAPALENE AND BENZOYL PEROXIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.